TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Lemongrass Medical Consulting&Invest AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
64
|
119
|
125 |
| Financial expenses |
1
|
1
|
1 |
| Earnings before taxes |
2
|
-9
|
20 |
| EBITDA |
3
|
-8
|
21 |
| Total assets |
12
|
23
|
32 |
| Current assets |
5
|
15
|
24 |
| Current liabilities |
25
|
39
|
39 |
| Equity capital |
-13
|
-16
|
-7 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
-108.3%
|
-69.6%
|
-21.9% |
| Turnover per employee |
64
|
119
|
125 |
| Profit as a percentage of turnover |
3.1%
|
-7.6%
|
16.0% |
| Return on assets (ROA) |
25.0%
|
-34.8%
|
65.6% |
| Current ratio |
20.0%
|
38.5%
|
61.5% |
| Return on equity (ROE) |
-15.4%
|
56.2%
|
-285.7% |
| Change turnover |
-51
|
-6
|
-2 |
| Change turnover % |
-44%
|
-5%
|
-1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.